To Evaluate the Performance and Safety of RisoR Crest Everolimus Eluting Coronary Stent System

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 2000 participants.

Also called NCT07098195

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 2,000 participants (planned count) (from the registry)
Sponsor
Poly Medicure Limited (from the registry)
Registry
  • NCT NCT07098195
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07098195. Allocation not applicable; no masking; primary purpose treatment. Start 2025-08-18 (anticipated); primary completion 2027-08-17 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
To Evaluate the Performance and Safety of RisoR Crest Everolimus Eluting Coronary Stent System
Acronym
PACIFIER
Condition
Coronary Artery Stenosis
Condition
de Novo Lesions in Native Coronary Arteries
Intervention (Device)
Coronary Stent
Lead sponsor
Poly Medicure Limited (class: industry)

Record details

Record id
cardio:ct-nct07098195
Content hash
48641a86563a5032ec6dadcbe6ad4d2252e7a7c8032e59fcaf40ef8cf4898631